Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet"]
Optic neuritis in neuromyelitis optica.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
AMP-Activated Protein Kinase Signaling Protects Oligodendrocytes that Restore Central Nervous System Functions in an Experimental Autoimmune Encephalomyelitis Model.
Natural killer cells and their receptors in multiple sclerosis.
Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases.
Cerebral vein changes in relapsing-remitting multiple sclerosis demonstrated by three-dimensional enhanced T (2) (*) -weighted angiography at 3.0 T.
Cognitive reserve in ageing and Alzheimer's disease.
Molecular biomarkers of neurodegeneration.
Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy.
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.
Charcot-Marie-Tooth Disease: An Overview of Genotypes, Phenotypes, and Clinical Management Strategies.
Microsurgical Pontine Descending Tractotomy in Cases of Intractable Trigeminal Neuralgia.
B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions.
Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study.
Non-local spatial regularization of MRI T2 relaxation images for myelin water quantification.
Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
Stress caused adverse entanglement of the nervous and autoimmune systems: A case for MS.
Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.
Interferon-Beta Induces Distinct Gene Expression Response Patterns in Human Monocytes versus T cells.
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.
IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.
Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review.
Pages
« first
‹ previous
…
432
433
434
435
436
437
438
439
440
…
next ›
last »